Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Methods Mol Biol ; 2418: 25-39, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35119657

RESUMEN

Phosphorylation of the serine residues in estrogen receptor (ER) α is important in transcriptional activation. Hence, methods to detect such posttranslational modification events are valuable. We describe, in detail, the analysis of the phosphorylated ERα by electrophoretic separation of proteins and subsequent immunoblotting techniques. In particular, phosphorylation of the ERα is one possible outcome of activation of the putative membrane estrogen receptor (mER), GPR30 or GPER1. Hence, phosphorylation represents a crosstalk event between GPR30 and ERα and may be important in estrogen-regulated physiology.


Asunto(s)
Receptor alfa de Estrógeno , Receptores Acoplados a Proteínas G , Estradiol , Receptor alfa de Estrógeno/metabolismo , Estrógenos/metabolismo , Immunoblotting , Fosforilación , Receptores Acoplados a Proteínas G/metabolismo , Serina/metabolismo
2.
Am J Occup Ther ; 74(1): 7401345020p1-7401345020p8, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32078521

RESUMEN

IMPORTANCE: Level II fieldwork is one of the last opportunities for students to learn from clinicians modeling how to gather practice-based data for research before independent practice. OBJECTIVE: To identify options for incorporating active research opportunities in the Level II fieldwork experience and the barriers that preclude these opportunities. DESIGN: Approximately 575 electronic surveys (QuestionPro), consisting of 31 questions, distributed to fieldwork sites. PARTICIPANTS: A convenience sample of fieldwork educators and clinical fieldwork coordinators recruited from sites in several states. OUTCOMES AND MEASURES: We hypothesized that the main obstacles to providing Level II fieldwork students with research experience were a lack of time resulting from productivity pressures and fieldwork educators' belief that Level II fieldwork should primarily focus on mastering clinical skills. RESULTS: One hundred thirteen surveys were started, and 95 were completed. Most respondents reported that Level II fieldwork students would benefit from participation in research. However, only two fieldwork sites with occupational therapists involved in research intentionally coordinated Level II fieldwork students in an active research opportunity. Clinical responsibilities and the lack of current experienced investigators at the fieldwork site were the most significant barriers to these opportunities. CONCLUSIONS AND RELEVANCE: Fieldwork educators identify ways for Level II fieldwork students to participate in research but typically do not have time or resources to eliminate identified barriers to research participation. Lost opportunities to participate in research in Level II fieldwork must be addressed to promote greater research inquiry in the future occupational therapy clinical workforce. WHAT THIS ARTICLE ADDS: The article adds to the literature describing the barriers to student participation in research activity during Level II Fieldwork and the types of research activity occupational therapy students participated in during a 12-wk rotation.


Asunto(s)
Terapeutas Ocupacionales , Terapia Ocupacional , Competencia Clínica , Humanos , Terapeutas Ocupacionales/estadística & datos numéricos , Terapia Ocupacional/educación , Estudiantes , Encuestas y Cuestionarios
3.
BMJ Case Rep ; 12(4)2019 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-30954956

RESUMEN

We report two women who were diagnosed with hypothyroidism due to what was thought to be Hashimoto's thyroiditis 18 and 16 years ago, respectively. They had been euthyroid on stable doses of levothyroxine for many years, and they presented to our clinic with clinically and biochemically overt hyperthyroidism that persisted even after stopping levothyroxine. Immunological and imaging workups were consistent with Graves' disease. Both patients were treated medically and then received definitive treatment. To our knowledge, the intervals for these two conversions are among the longest conversion intervals reported in the medical literature.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Antitiroideos/uso terapéutico , Enfermedad de Graves/fisiopatología , Enfermedad de Hashimoto/fisiopatología , Hipertiroidismo/inmunología , Hipotiroidismo/inmunología , Femenino , Enfermedad de Graves/complicaciones , Enfermedad de Graves/inmunología , Enfermedad de Graves/terapia , Enfermedad de Hashimoto/complicaciones , Enfermedad de Hashimoto/inmunología , Enfermedad de Hashimoto/terapia , Humanos , Hipertiroidismo/etiología , Hipertiroidismo/fisiopatología , Hipertiroidismo/terapia , Hipotiroidismo/etiología , Hipotiroidismo/fisiopatología , Hipotiroidismo/terapia , Metimazol/uso terapéutico , Persona de Mediana Edad , Propranolol/uso terapéutico , Tiroidectomía , Tiroxina/efectos adversos , Tiroxina/uso terapéutico , Resultado del Tratamiento
4.
Methods Mol Biol ; 1366: 457-470, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26585157

RESUMEN

Phosphorylation of the serine residues in estrogen receptor (ER) α is important in transcriptional activation. Hence, methods to detect such posttranslational modification events are valuable. We describe, in detail, the analysis of the phosphorylated ERα by electrophoretic separation of proteins and subsequent immuno-blotting techniques. In particular, phosphorylation of the ERα is one possible outcome of activation of the putative membrane estrogen receptor (mER), GPR30. Hence, phosphorylation represents a cross talk event between GPR30 and ERα and may be important in estrogen-regulated physiology.


Asunto(s)
Receptor alfa de Estrógeno/metabolismo , Hipocampo/metabolismo , Receptores de Estrógenos/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Animales , Western Blotting , Línea Celular , Ciclopentanos/farmacología , Electroforesis en Gel de Poliacrilamida , Estradiol/farmacología , Receptor alfa de Estrógeno/agonistas , Femenino , Hipocampo/efectos de los fármacos , Masculino , Ratones , Orquiectomía , Ovariectomía , Fosforilación , Quinolinas/farmacología , Receptor Cross-Talk , Receptores Acoplados a Proteínas G/agonistas , Serina , Transducción de Señal/efectos de los fármacos , Flujo de Trabajo
5.
PLoS One ; 10(8): e0136894, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26317344

RESUMEN

BACKGROUND: Previous studies of compatibility of calcium chloride (CaCl2) and phosphates have not included particle counts in the range specified by the United States Pharmacopeia. Micro-flow imaging techniques have been shown to be comparable to light obscuration when determining particle count and size in pharmaceutical solutions. OBJECTIVE: The purpose of this study was to do compatibility testing for parenteral nutrition (PN) solutions containing CaCl2 using dynamic light scattering and micro-flow imaging techniques. METHODS: Solutions containing TrophAmine (Braun Medical Inc, Irvine, CA), CaCl2, and sodium phosphate (NaPhos) were compounded with and without cysteine. All solutions contained standard additives to neonatal PN solutions including dextrose, trace metals, and electrolytes. Control solutions contained no calcium or phosphate. Solutions were analyzed for particle size and particle count. Means of Z-average particle size and particle counts of controls were determined. Study solutions were compared to controls and United States Pharmacopeia (USP) Chapter 788 guidelines. The maximum amount of Phos that was compatible in solutions that contained at least 10 mmol/L of Ca in 2.5% amino acids (AA) was determined. Compatibility of these solutions was verified by performing analyses of 5 repeats of these solutions. Microscopic analyses of the repeats were also performed. RESULTS: Amounts of CaCl2 and NaPhos that were compatible in solutions containing 1.5%, 2%, 2.5%, and 3% AA were determined. The maximum amount of NaPhos that could be added to TrophAmine solutions of > = 2.5% AA containing at least 10 mmol/L of CaCl2 was 7.5 mmol/L. Adding 50 mg/dL of cysteine increased the amount of NaPhos that could be added to solutions containing 10 mmol/L of CaCl2 to 10 mmol/L. CONCLUSION: Calcium chloride can be added to neonatal PN solutions containing NaPhos in concentrations that can potentially provide an intravenous intake of adequate amounts of calcium and phosphorus.


Asunto(s)
Cloruro de Calcio/análisis , Cisteína/administración & dosificación , Soluciones para Nutrición Parenteral/análisis , Fosfatos/análisis , Aminoácidos/química , Precipitación Química , Dispersión Dinámica de Luz/métodos , Humanos , Recién Nacido , Nutrición Parenteral/métodos , Tamaño de la Partícula
6.
PLoS One ; 9(9): e106825, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25192060

RESUMEN

INTRODUCTION: We have previously reported results of precipitation studies for neonatal parenteral nutrition solutions containing calcium chloride and sodium phosphate using visual methods to determine compatibility. The purpose of this study was to do further testing of compatibility for solutions containing calcium chloride using more sensitive methods. METHODS: Solutions of Trophamine (Braun Medical Inc, Irvine, CA) and Premasol (Baxter Pharmaceuticals, Deerfield, IL) were compounded with calcium chloride and potassium phosphate. Controls contained no calcium or phosphate. After incubation at 37° for 24 hours solutions without visual precipitation were analyzed to determine mean particle size using dynamic light scattering from a laser light source. RESULTS: Particle sizes were similar for control solutions and those without visual precipitation and a mean particle size <1000 nm. Compatible solutions were defined as those with added calcium and phosphate with no visual evidence of precipitation and mean particle size <1000 nm. In solutions containing 2.5-3% amino acids and 10 mmol/L of calcium chloride the maximum amount of potassium phosphate that was compatible was 7.5 mmol/L. CONCLUSION: Maximum amounts of phosphate that could be added to parenteral nutrition solutions containing Trophamine and calcium chloride were about 7.5-10 mmol/L less for a given concentration of calcium based upon laser methodology compared to visual techniques to determine compatibility. There were minor differences in compatibility when adding calcium chloride and potassium phosphate to Premasol versus Trophamine.


Asunto(s)
Aminoácidos/química , Cloruro de Calcio/química , Dispersión Dinámica de Luz/métodos , Electrólitos/química , Glucosa/química , Soluciones para Nutrición Parenteral/análisis , Precipitación Química , Humanos , Recién Nacido , Nutrición Parenteral/métodos , Tamaño de la Partícula , Soluciones/química
7.
Brain Behav ; 4(1): 51-9, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24653954

RESUMEN

The GPR30 is a novel estrogen receptor (ER) that is a candidate membrane ER based on its binding to 17ß estradiol and its rapid signaling properties such as activation of the extracellular-regulated kinase (ERK) pathway. Its distribution in the mouse limbic system predicts a role for this receptor in the estrogenic modulation of anxiety behaviors in the mouse. A previous study showed that chronic administration of a selective agonist to the GPR30 receptor, G-1, in the female rat can improve spatial memory, suggesting that GPR30 plays a role in hippocampal-dependent cognition. In this study, we investigated the effect of a similar chronic administration of G-1 on behaviors that denote anxiety in adult ovariectomized female mice, using the elevated plus maze (EPM) and the open field test as well as the activation of the ERK pathway in the hippocampus. Although estradiol benzoate had no effect on behaviors in the EPM or the open field, G-1 had an anxiolytic effect solely in the open field that was independent of ERK signaling in either the ventral or dorsal hippocampus. Such an anxiolytic effect may underlie the ability of G-1 to increase spatial memory, by acting on the hippocampus.


Asunto(s)
Ansiedad/metabolismo , Conducta Animal/fisiología , Hipocampo/metabolismo , Sistema de Señalización de MAP Quinasas/fisiología , Receptores de Estrógenos/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Animales , Ansiolíticos/farmacología , Conducta Animal/efectos de los fármacos , Ciclopentanos/farmacología , Femenino , Hipocampo/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Ratones , Ratones Endogámicos C57BL , Ovariectomía , Quinolinas/farmacología , Receptores Acoplados a Proteínas G/agonistas
8.
Lab Chip ; 14(1): 172-7, 2014 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-24202525

RESUMEN

We present a disease-on-a-chip model in which cancer grows within phenotypically normal breast luminal epithelium on semicircular acrylic support mimicking portions of mammary ducts. The cells from tumor nodules developing within these hemichannels are morphologically distinct from their counterparts cultured on flat surfaces. Moreover, tumor nodules cocultured with the luminal epithelium in hemichannels display a different anticancer drug sensitivity compared to nodules cocultured with the luminal epithelium on a flat surface and to monocultures of tumor nodules. The mimicry of tumor development within the epithelial environment of mammary ducts provides a framework for the design and test of anticancer therapies.


Asunto(s)
Técnicas de Cultivo de Célula/métodos , Glándulas Mamarias Humanas/citología , Técnicas Analíticas Microfluídicas/métodos , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Técnicas de Cultivo de Célula/instrumentación , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Técnicas de Cocultivo , Células Epiteliales/citología , Femenino , Humanos , Integrina alfa6/metabolismo , Glándulas Mamarias Humanas/metabolismo , Técnicas Analíticas Microfluídicas/instrumentación , Proteína de la Zonula Occludens-1/metabolismo
9.
Steroids ; 81: 49-56, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24240011

RESUMEN

The GPR30, a former orphan GPCR, is a putative membrane estrogen receptor that can activate rapid signaling pathways such as extracellular regulated kinase (ERK) in a variety of cells and may contribute to estrogen's effects in the central nervous system. The distribution of GPR30 in the limbic system predicts a role for this receptor in the regulation of learning and memory and anxiety by estrogens. Though acute G-1 treatment is reported to be anxiogenic in ovariectomised female mice and in gonadally intact male mice, the effect of GPR30 activation is unknown in gonadectomised male mice. In this study, we show that an acute administration of G-1 to gonadectomised male mice, but not female mice, was anxiolytic on an elevated plus maze task, without affecting locomotor activity. In addition, though G-1 treatment did not regulate ERK, it was associated with increased estrogen receptor (ER)α phosphorylation in the ventral, but not dorsal, hippocampus of males. In the female, G-1 increased the ERK activation solely in the dorsal hippocampus, independent of state anxiety. This is the first study to report an anxiolytic effect of GPR30 activation in male mice, in a rapid time frame that is commensurate with non-genomic signaling by estrogen.


Asunto(s)
Ansiedad/tratamiento farmacológico , Ansiedad/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Animales , Corticosterona/metabolismo , Ciclopentanos/farmacología , Estradiol/farmacología , Receptor alfa de Estrógeno/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Femenino , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Orquiectomía , Ovariectomía , Fosforilación/efectos de los fármacos , Quinolinas/farmacología , Receptores de Estrógenos , Receptores Acoplados a Proteínas G/agonistas , Factores Sexuales , Transducción de Señal
10.
J Steroid Biochem Mol Biol ; 139: 45-53, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24121066

RESUMEN

While many physiological effects of estrogens (E) are due to regulation of gene transcription by liganded estrogen receptors (ERs), several effects are also mediated, at least in part, by rapid non-genomic actions of E. Though the relative importance of rapid versus genomic effects in the central nervous system is controversial, we showed previously that membrane-limited effects of E, initiated by an estradiol bovine serum albumin conjugate (E2-BSA), could potentiate transcriptional effects of 17ß-estradiol from an estrogen response element (ERE)-reporter in neuroblastoma cells. Here, using specific inhibitors and activators in a pharmacological approach, we show that activation of phosphatidylinositol-3-phosphate kinase (PI3K) and mitogen activated protein kinase (MAPK) pathways, dependent on a Gαq coupled receptor signaling are important in this transcriptional potentiation. We further demonstrate, using ERα phospho-deficient mutants, that E2-BSA mediated phosphorylation of ERα is one mechanism to potentiate transcription from an ERE reporter construct. This study provides a possible mechanism by which signaling from the membrane is coupled to transcription in the nucleus, providing an integrated view of hormone signaling in the brain.


Asunto(s)
Receptor alfa de Estrógeno/metabolismo , Sistema de Señalización de MAP Quinasas , Androstadienos/farmacología , Butadienos/farmacología , Línea Celular Tumoral , Núcleo Celular/metabolismo , Activación Enzimática , Estradiol/farmacología , Estradiol/fisiología , Receptor alfa de Estrógeno/genética , Células HEK293 , Humanos , Proteínas Quinasas Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Neuroblastoma , Nitrilos/farmacología , Fosfatidilinositol 3-Quinasas/metabolismo , Inhibidores de las Quinasa Fosfoinosítidos-3 , Fosforilación , Procesamiento Proteico-Postraduccional , Proteínas Proto-Oncogénicas c-akt/metabolismo , Elementos de Respuesta , Albúmina Sérica Bovina/farmacología , Albúmina Sérica Bovina/fisiología , Transcripción Genética , Activación Transcripcional , Wortmanina
11.
Appl Radiat Isot ; 78: 57-61, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23672965

RESUMEN

Calcium oxalate precipitation is the first step in preparation of biological samples for (41)Ca analysis by accelerator mass spectrometry. A simplified protocol for large-volume human urine samples was characterized, with statistically significant increases in ion current and decreases in interference. This large-volume assay minimizes cost and effort and maximizes time after (41)Ca administration during which human samples, collected over a lifetime, provide (41)Ca:Ca ratios that are significantly above background.


Asunto(s)
Radioisótopos de Calcio/orina , Calcio/aislamiento & purificación , Calcio/orina , Espectrometría de Masas/instrumentación , Aceleradores de Partículas/instrumentación , Manejo de Especímenes/instrumentación , Urinálisis/instrumentación , Radioisótopos de Calcio/química , Diseño de Equipo , Análisis de Falla de Equipo , Humanos
12.
Oecologia ; 172(3): 915-24, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23242425

RESUMEN

Habitat invasibility has been found to increase dramatically following the alteration of ecosystem properties by a nonnative species. Robinia pseudoacacia, black locust, is a nitrogen-fixing, clonal tree species that aggressively invades open habitats and expands outside of plantations worldwide. Robinia pseudoacacia stands in Cape Cod National Seashore were particularly susceptible to a hurricane in 1991 that caused widespread blowdown and a dramatic reduction in Robinia in some stands. We used this change to investigate the lasting ecological effects of this nonnative species on this upland coastal ecosystem. We established replicate clusters of 20 × 20 m field plots within 50 m of each other that contained native pitch pine (Pinus rigida) and oak (Quercus velutina, Q. alba) forest, living Robinia stands, and stands in which Robinia was eliminated or reduced to less than 5% cover by the hurricane. Net nitrification and extractable soil nitrate concentration differed significantly between stand types, in the order Robinia > former Robinia > pine-oak. Nonnative species cover differed significantly between each stand type, in the order Robinia > former Robinia > pine-oak. Invasion of Robinia pseudoacacia increased soil net nitrification and nitrogen availability and precipitated a change in forest species composition that favored nonnative species. The presence of elevated soil nitrogen and nonnative species persisted at least 14 years after the removal of the original invading tree species, suggesting that the invasion of a tree species left a legacy of altered soil biogeochemistry, a higher number of nonnative species, and greater nonnative species cover.


Asunto(s)
Ecosistema , Fijación del Nitrógeno , Robinia/fisiología , Árboles , Suelo
13.
Toxicol Sci ; 130(1): 191-204, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22831969

RESUMEN

Mean blood cadmium (B-Cd) concentrations are two- to threefold higher in smokers than in nonsmokers. The basis for this phenomenon is not well understood. We conducted a detailed, multifaceted study of cadmium exposure in smokers. Groups were older smokers (62±4 years, n = 25, 20% male) and nonsmokers (62±3 years, n = 16, 31% male). Each subject's cigarettes were machine smoked, generating individually paired measures of inhaled cadmium (I-Cd) versus B-Cd; I-Cd and B-Cd were each evaluated three times, at monthly intervals. Urine cadmium (U-Cd) was analyzed for comparison. In four smokers, a duplicate-diet study was conducted, along with a kinetic study of plasma cadmium versus B-Cd. Female smokers had a mean B-Cd of 1.21ng Cd/ml, with a nearly 10-fold range (0.29-2.74ng Cd/ml); nonsmokers had a lower mean B-Cd, 0.35ng Cd/ml (p < 0.05), and narrower range (0.20-0.61ng Cd/ml). Means and ranges for males were similar. Estimates of cadmium amounts inhaled daily for our subjects smoking ≥ 20 cigarettes/day were far less than the 15 µg Cd reported to be ingested daily via diet. This I-Cd amount was too low to alone explain the 3.5-fold elevation of B-Cd in our smokers, even assuming greater cadmium absorption via lungs than gastrointestinal tract; cadmium accumulated in smokers' lungs may provide the added cadmium. Finally, B-Cd appeared to be linearly related to I-Cd values in 75% of smokers, whereas 25% had far higher B-Cd, implying a possible heterogeneity among smokers regarding circulating cadmium concentrations and potentially cadmium toxicity.


Asunto(s)
Compuestos de Cadmio/análisis , Exposición por Inhalación/efectos adversos , Nicotiana/efectos adversos , Posmenopausia/metabolismo , Fumar/metabolismo , Compuestos de Cadmio/metabolismo , Monitoreo del Ambiente , Femenino , Humanos , Masculino , Persona de Mediana Edad , Humo/efectos adversos , Fumar/efectos adversos
14.
Surgery ; 150(4): 752-8, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22000188

RESUMEN

BACKGROUND: To evaluate resident case volume after discontinuation of a laparoscopic surgery fellowship, and to examine disparities in patient care over the same time period. METHODS: Resident case logs were compared for a 2-year period before and 1 year after discontinuing the fellowship, using a 2-sample t test. Databases for bariatric and esophageal surgery were reviewed to compare operative time, length of stay (LOS), and complication rate by resident or fellow over the same time period using a 2-sample t test. RESULTS: Increases were seen in senior resident advanced laparoscopic (Mean Fellow Year = 21 operations vs Non Fellow Year = 61, P < 0.01), esophageal (1 vs 11, P < .01) and bariatric volume (9 vs 36, P < .01). Junior resident laparoscopic volume increased (P < 0.05). No difference in LOS or complication rate was seen with resident vs fellow assistant. Operative time was greater for gastric bypass with resident assistant (152 ± 51 minutes vs 138 ± 53, P < .05). CONCLUSION: Discontinuing a laparoscopic fellowship significantly increases resident case volume in laparoscopic surgery. Operative time for complex operations may increase in the absence of a fellow. Other patient outcomes are not affected by this change.


Asunto(s)
Cirugía General/educación , Internado y Residencia , Laparoscopía/educación , Centros Médicos Académicos , Cirugía Bariátrica/educación , Cirugía Bariátrica/estadística & datos numéricos , Chicago , Bases de Datos Factuales , Procedimientos Quirúrgicos del Sistema Digestivo/educación , Procedimientos Quirúrgicos del Sistema Digestivo/estadística & datos numéricos , Becas , Cirugía General/estadística & datos numéricos , Disparidades en Atención de Salud , Humanos , Laparoscopía/estadística & datos numéricos , Carga de Trabajo/estadística & datos numéricos
15.
Cardiol Rev ; 19(2): 95-100, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21285670

RESUMEN

The complex mechanism of platelet activation creates an optimal target for pharmacological treatment in patients with acute coronary syndromes. Current antiplatelet medications that are used in addition to aspirin include the thienopyridines, clopidogrel and prasugrel, but there are several limitations to the use of these medications. Clopidogrel and prasugrel irreversibly bind to the P2Y12 receptor, creating a prolonged antiplatelet effect which can be undesirable when surgery is needed. Clopidogrel requires hepatic activation and produces variable platelet inhibition based on genetic polymorphisms. Prasugrel has more consistent platelet inhibition than clopidogrel but carries with it an increased risk of serious bleeds. Ticagrelor is a drug in a new chemical class that reversibly binds the P2Y12 receptor and noncompetitively blocks adenosine diphosphate-induced platelet activation. It was specifically designed to address the limitations of the available antiplatelet agents while maintaining comparable or better antiplatelet effects. It does not require metabolic activation and demonstrates greater platelet inhibition, a faster offset of action and comparable bleeding risk compared to clopidogrel. The pivotal PLATO (The Study of Platelet Inhibition and Patient Outcomes) trial in patients with an acute coronary syndrome demonstrated improved cardiovascular outcomes, including a reduction in myocardial infarctions and vascular events using ticagrelor as compared to clopidogrel with comparable rates of major bleeds. A puzzling finding from that trial was the lack of benefit with ticagrelor in patients enrolled from the United States, which has led to ticagrelor not being approved at this time in this country. The main adverse events with ticagrelor are bleeding and dyspnea, the latter of which is of unclear etiology and of unknown long-term clinical concern. In summary, ticagrelor is an exciting new oral antiplatelet drug that seems to be more efficacious than clopidogrel, with comparable safety. Whether issues of geographic disparities in response and the unusual side effect of dyspnea ultimately prove problematic has yet to be determined. Nonetheless, ticagrelor is a drug that has the potential to change the standard of care of patients with acute coronary syndromes.


Asunto(s)
Síndrome Coronario Agudo/tratamiento farmacológico , Adenosina/análogos & derivados , Inhibidores de Agregación Plaquetaria/uso terapéutico , Antagonistas del Receptor Purinérgico P2/uso terapéutico , Adenosina/administración & dosificación , Adenosina/efectos adversos , Adenosina/uso terapéutico , Administración Oral , Clopidogrel , Resistencia a Medicamentos , Disnea , Humanos , Inhibidores de Agregación Plaquetaria/administración & dosificación , Inhibidores de Agregación Plaquetaria/efectos adversos , Antagonistas del Receptor Purinérgico P2/administración & dosificación , Antagonistas del Receptor Purinérgico P2/efectos adversos , Piridinas/administración & dosificación , Piridinas/efectos adversos , Piridinas/uso terapéutico , Ticagrelor , Ticlopidina/administración & dosificación , Ticlopidina/efectos adversos , Ticlopidina/análogos & derivados , Ticlopidina/uso terapéutico
16.
Endocrinology ; 151(7): 3277-85, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20463054

RESUMEN

Hypothalamic tuberoinfundibular dopaminergic (TIDA) neurons secrete dopamine, which inhibits pituitary prolactin (PRL) secretion. PRL has demonstrated neurotrophic effects on TIDA neuron development in PRL-, GH-, and TSH-deficient Ames (df/df) and Snell (dw/dw) dwarf mice. However, both PRL and PRL receptor knockout mice exhibit normal-sized TIDA neuron numbers, implying GH and/or TSH influence TIDA neuron development. The current study investigated the effect of porcine (p) GH on TIDA neuron development in Ames dwarf hypothalamus. Normal (DF/df) and dwarf mice were treated daily with pGH or saline beginning at 3 d of age for a period of 42 d. After treatment, brains were analyzed using catecholamine histofluorescence, tyrosine hydroxylase immunocytochemistry, and bromodeoxyuridine (BrdU) immunocytochemistry to detect BrdU incorporation. DF/df males and df/df treated with pGH experienced increased (P

Asunto(s)
Dopamina/metabolismo , Enanismo/metabolismo , Hormona del Crecimiento/farmacología , Neuronas/citología , Neuronas/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Peso Corporal/genética , Catecolaminas/metabolismo , Femenino , Genotipo , Hormona del Crecimiento/administración & dosificación , Hipotálamo/citología , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Inmunohistoquímica , Masculino , Ratones , Neuronas/metabolismo , Factores Sexuales , Porcinos , Factores de Tiempo , Tirosina 3-Monooxigenasa/metabolismo
17.
Ecotoxicol Environ Saf ; 73(4): 534-40, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20138362

RESUMEN

Regulation of waterbodies impaired due to sediment toxicity may require development of Total Maximum Daily Load (TMDL) allocations to reduce chemicals of concern. A key step in this process is the identification of chemicals responsible for toxicity, and sediment toxicity identification evaluation procedures (TIEs) are the primary tools used to accomplish this. Several sites in San Diego Bay (CA, USA) are listed as impaired due to sediment toxicity associated with organic chemicals and metals, and due to degraded benthic macroinvertebrate communities. Sediment was collected from one of these sites, at the confluence of Switzer Creek in San Diego Harbor. The sediment was subjected to selected whole-sediment TIE treatments to evaluate the efficacy of these procedures for identifying the causes of toxicity at Switzer Creek. Toxicity was assessed using the estuarine amphipod Eohaustorius estuarius. The results indicated that toxicity of San Diego Bay sediment was likely partly due to mixtures of pyrethroid pesticides. These experiments showed that the effectiveness of the individual TIE procedures varied by treatment. Variability was mainly due to inconsistency between results of samples subjected to various Phase II TIE procedures, including chemical analyses of samples subjected to high-pressure liquid chromatography and direct analyses of acetone extractions of carbonaceous resin. The procedures require further refinement to ensure maximum sorption and complete elution and detection of sorbed chemicals. Despite these inconsistencies, the results indicate the utility of these procedures for identifying chemicals of concern in this system.


Asunto(s)
Monitoreo del Ambiente/métodos , Sedimentos Geológicos/química , Contaminantes Químicos del Agua/toxicidad , Anfípodos/química , Animales , California , Contaminantes Químicos del Agua/análisis
18.
Aquat Toxicol ; 95(3): 230-8, 2009 Nov 27.
Artículo en Inglés | MEDLINE | ID: mdl-19850363

RESUMEN

With maritime transport of crude oil from Alaska to California, there is significant potential for a catastrophic spill which could impact migrating salmon. Therefore, this study compared the lethal and sublethal metabolic actions of the water-accommodated fraction (WAF) and the chemically enhanced WAF (CEWAF, via Corexit 9500) of Prudhoe Bay crude oil in smolts of Chinook salmon (Onchorhyncus tshawytscha). After 96-h exposure to the CEWAF, the resulting LC50 was some 20 times higher (i.e., less toxic) than that of the WAF. Muscle and liver samples from surviving fish were collected and low-molecular weight metabolites were analyzed using one-dimensional (1)H and projections of two-dimensional (1)H J-resolved NMR. Principal component analysis (PCA), employed to analyze NMR spectra and identify most variance from the samples, revealed age-related metabolic changes in the fish within the replicated studies, but few consistent metabolic effects from the treatments. However, ANOVA results demonstrated that the dose-response metabolite patterns are both metabolite- and organ-dependent. In general, exposure to either WAF or CEWAF resulted in an increase of amino acids (i.e., valine, glutamine and glutamate) and a decrease of both organic osmolytes (i.e., glycerophosphorylcholine) and energetic substrates (i.e., succinate). The simultaneous increase of formate and decrease of glycerophosphorylcholine in the liver, or the decrease of glycerophosphorylcholine in muscle, may serve as sensitive sublethal biomarkers for WAF or CEWAF exposures, respectively. In conclusion, dispersant treatment significantly decreased the lethal potency of crude oil to salmon smolts, and the NMR-based metabolomics approach provided a sensitive means to characterize the sublethal metabolic actions.


Asunto(s)
Metabolómica , Petróleo/metabolismo , Petróleo/toxicidad , Salmón/metabolismo , Contaminantes Químicos del Agua/metabolismo , Contaminantes Químicos del Agua/toxicidad , Animales , Dosificación Letal Mediana , Hígado/metabolismo , Músculos/metabolismo
19.
Chemosphere ; 74(5): 648-53, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19081602

RESUMEN

Phase I whole sediment toxicity identification evaluation (TIE) methods have been developed to characterize the cause of toxicity as organic chemicals, metals, or ammonia. In Phase II identification treatments, resins added to whole sediment to reduce toxicity caused by metals and organics can be separated and eluted much like solid-phase extraction (SPE) columns are eluted for interstitial water. In this study, formulated reference sediments spiked with toxic concentrations of copper, fluoranthene, and nonylphenol were subjected to whole sediment and interstitial water TIE treatments to evaluate Phase I and II TIE procedures for identifying the cause of toxicity to Hyalella azteca. Phase I TIE treatments consisted of adding adsorbent resins to whole sediment, and using SPE columns to remove spiked chemicals from interstitial water. Phase II treatments consisted of eluting resins and SPE columns and the preparation and testing of eluates for toxicity and chemistry. Whole sediment resins and SPE columns significantly reduced toxicity, and the eluates from all treatments contained toxic concentrations of the spiked chemical except for interstitial water fluoranthene. Toxic unit analysis based on median lethal concentrations (LC50s) allowed for the comparison of chemical concentrations among treatments, and demonstrated that the bioavailability of some chemicals was reduced in some samples and treatments. The concentration of fluoranthene in the resin eluate closely approximated the original interstitial water concentration, but the resin eluate concentrations of copper and nonylphenol were much higher than the original interstitial water concentrations. Phase II whole sediment TIE treatments provided complementary lines of evidence to the interstitial water TIE results.


Asunto(s)
Monitoreo del Ambiente/métodos , Sedimentos Geológicos/química , Contaminantes Químicos del Agua/análisis , Contaminantes Químicos del Agua/toxicidad , Agua/química , Cobre/análisis , Cobre/toxicidad , Fluorenos/análisis , Fluorenos/toxicidad , Agua Dulce/análisis , Agua Dulce/química , Sedimentos Geológicos/análisis , Fenoles/análisis , Fenoles/toxicidad
20.
Endocrinology ; 149(4): 2010-8, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18096658

RESUMEN

Pituitary prolactin (PRL) secretion is inhibited by dopamine (DA) released into the portal circulation from hypothalamic tuberoinfundibular DA (TIDA) neurons. Ames (df/df) and Snell (dw/dw) dwarf mice lack PRL, GH, and TSH, abrogating feedback and resulting in a reduced hypophysiotropic TIDA population. In Ames df/df, ovine PRL administration for 30 d during early postnatal development increases the TIDA neuron number to normal, but 30 d PRL treatment of adult df/df does not. The present study investigated the effects of homologous PRL, administered via renal capsule pituitary graft surgery for 4 or 6 months, on hypothalamic DA neurons in adult Snell dw/dw mice using catecholamine histofluorescence, tyrosine hydroxylase immunocytochemistry, and bromodeoxyuridine immunocytochemistry. PRL treatment did not affect TIDA neuron number in normal mice, but 4- and 6-month PRL-treated dw/dw had significantly increased (P < or = 0.01) TIDA (area A12) neurons compared with untreated dw/dw. Snell dwarfs treated with PRL for 6 months had more (P < or = 0.01) TIDA neurons than 4-month PRL-treated dw/dw, but lower (P < or = 0.01) numbers than normal mice. Periventricular nucleus (area A14) neuron number was lower in dwarfs than in normal mice, regardless of treatment. Zona incerta (area A13) neuron number was unchanged among phenotypes and treatments. Prolactin was unable to induce differentiation of a normal-sized A14 neuron population in dw/dw. Bromodeoxyuridine incorporation was lower (P < or = 0.01) in 6-month PRL-treated normal mice than in 6-month PRL-treated dwarfs in the subventricular zone of the lateral ventricle and in the dentate gyrus, and lower (P < or = 0.05) in 4-month untreated dwarfs than in 4-month untreated normal mice in the median eminence and the periventricular area surrounding the third ventricle. Thus, a PRL-sensitive TIDA neuron population exists in adult Snell dwarf mice when replacement uses homologous hormone and/or a longer duration. This finding indicates that there is potential for neuronal differentiation beyond early developmental periods and suggests plasticity within the mature hypothalamus.


Asunto(s)
Dopamina/fisiología , Enanismo Hipofisario/patología , Hipotálamo/efectos de los fármacos , Prolactina/administración & dosificación , Animales , Peso Corporal/efectos de los fármacos , Bromodesoxiuridina/metabolismo , Diferenciación Celular/efectos de los fármacos , Enanismo Hipofisario/genética , Femenino , Masculino , Ratones , Hipófisis/trasplante , Tirosina 3-Monooxigenasa/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...